108 related articles for article (PubMed ID: 10370177)
1. Perivascular delivery of heparin for the reduction of smooth muscle cell proliferation after endothelial injury.
Teomim D; Fishbien I; Golomb G; Orloff L; Mayberg M; Domb AJ
J Control Release; 1999 Jun; 60(1):129-42. PubMed ID: 10370177
[TBL] [Abstract][Full Text] [Related]
2. Perivascular graft heparin delivery using biodegradable polymer wraps.
Edelman ER; Nathan A; Katada M; Gates J; Karnovsky MJ
Biomaterials; 2000 Nov; 21(22):2279-86. PubMed ID: 11026634
[TBL] [Abstract][Full Text] [Related]
3. Effect of controlled adventitial heparin delivery on smooth muscle cell proliferation following endothelial injury.
Edelman ER; Adams DH; Karnovsky MJ
Proc Natl Acad Sci U S A; 1990 May; 87(10):3773-7. PubMed ID: 2339120
[TBL] [Abstract][Full Text] [Related]
4. Localized delivery of heparin to angioplasty sites with iontophoresis.
Mitchel JF; Azrin MA; Fram DB; Bow LM; McKay RG
Cathet Cardiovasc Diagn; 1997 Jul; 41(3):315-23. PubMed ID: 9213031
[TBL] [Abstract][Full Text] [Related]
5. Decreased platelet deposition and smooth muscle cell proliferation after intramural heparin delivery with hydrogel-coated balloons.
Azrin MA; Mitchel JF; Fram DB; Pedersen CA; Cartun RW; Barry JJ; Bow LM; Waters DD; McKay RG
Circulation; 1994 Jul; 90(1):433-41. PubMed ID: 8026030
[TBL] [Abstract][Full Text] [Related]
6. Localized release of perivascular heparin inhibits intimal proliferation after endothelial injury without systemic anticoagulation.
Okada T; Bark DH; Mayberg MR
Neurosurgery; 1989 Dec; 25(6):892-8. PubMed ID: 2601819
[TBL] [Abstract][Full Text] [Related]
7. Perivascular delivery of resolvin D1 inhibits neointimal hyperplasia in a rat model of arterial injury.
Wu B; Mottola G; Chatterjee A; Lance KD; Chen M; Siguenza IO; Desai TA; Conte MS
J Vasc Surg; 2017 Jan; 65(1):207-217.e3. PubMed ID: 27034112
[TBL] [Abstract][Full Text] [Related]
8. Removal of heparan sulfate by heparinase treatment inhibits FGF-2-dependent smooth muscle cell proliferation in injured rat carotid arteries.
Kinsella MG; Irvin C; Reidy MA; Wight TN
Atherosclerosis; 2004 Jul; 175(1):51-7. PubMed ID: 15186946
[TBL] [Abstract][Full Text] [Related]
9. Fibrin glue containing fibroblast growth factor type 1 and heparin with autologous endothelial cells reduces intimal hyperplasia in a canine carotid artery balloon injury model.
Zarge JI; Huang P; Husak V; Kim DU; Haudenschild CC; Nord RM; Greisler HP
J Vasc Surg; 1997 May; 25(5):840-8; discussion 848-9. PubMed ID: 9152311
[TBL] [Abstract][Full Text] [Related]
10. Basic fibroblast growth factor enhances the coupling of intimal hyperplasia and proliferation of vasa vasorum in injured rat arteries.
Edelman ER; Nugent MA; Smith LT; Karnovsky MJ
J Clin Invest; 1992 Feb; 89(2):465-73. PubMed ID: 1371124
[TBL] [Abstract][Full Text] [Related]
11. Time course of smooth muscle cell proliferation after local drug delivery of low-molecular-weight heparin using a porous balloon catheter.
Oberhoff M; Herdeg C; Baumbach A; Shamet K; Kranzhöfer A; Weingärtner O; Rübsamen K; Kluge M; Karsch KR
Cathet Cardiovasc Diagn; 1997 Jul; 41(3):268-74. PubMed ID: 9213025
[TBL] [Abstract][Full Text] [Related]
12. Adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene inhibits vascular smooth muscle cell proliferation and neointima formation following balloon angioplasty of the rat carotid artery.
Chang MW; Ohno T; Gordon D; Lu MM; Nabel GJ; Nabel EG; Leiden JM
Mol Med; 1995 Jan; 1(2):172-81. PubMed ID: 8529096
[TBL] [Abstract][Full Text] [Related]
13. Influence of local delivery of the protein tyrosine kinase receptor inhibitor tyrphostin-47 on smooth-muscle cell proliferation in a rat carotid balloon-injury model.
Gottsauner-Wolf M; Jang Y; Lincoff AM; Cohen JL; Labhasetwar V; Poptic EJ; Forudi F; Guzman LA; DiCorleto PE; Levy RJ; Topol EJ; Ellis SG
Am Heart J; 1997 Mar; 133(3):329-34. PubMed ID: 9060802
[TBL] [Abstract][Full Text] [Related]
14. Modulation of vascular cell growth kinetics by local cytokine delivery from fibrin glue suspensions.
Shireman PK; Hampton B; Burgess WH; Greisler HP
J Vasc Surg; 1999 May; 29(5):852-61; discussion 862. PubMed ID: 10231637
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of smooth muscle cell proliferation in injured rat arteries. Interaction of heparin with basic fibroblast growth factor.
Lindner V; Olson NE; Clowes AW; Reidy MA
J Clin Invest; 1992 Nov; 90(5):2044-9. PubMed ID: 1430226
[TBL] [Abstract][Full Text] [Related]
16. Local delivery of heparin to balloon angioplasty sites with a new angiotherapy catheter: pharmacokinetics and effect on platelet deposition in the porcine model.
Fram DB; Mitchel JF; Azrin MA; Chow MS; Waters DD; McKay RG
Cathet Cardiovasc Diagn; 1997 Jul; 41(3):275-86. PubMed ID: 9213026
[TBL] [Abstract][Full Text] [Related]
17. Heparin and cilazapril together inhibit injury-induced intimal hyperplasia.
Clowes AW; Clowes MM; Vergel SC; Müller RK; Powell JS; Hefti F; Baumgartner HR
Hypertension; 1991 Oct; 18(4 Suppl):II65-9. PubMed ID: 1833326
[TBL] [Abstract][Full Text] [Related]
18. Neutrophil, not macrophage, infiltration precedes neointimal thickening in balloon-injured arteries.
Welt FG; Edelman ER; Simon DI; Rogers C
Arterioscler Thromb Vasc Biol; 2000 Dec; 20(12):2553-8. PubMed ID: 11116052
[TBL] [Abstract][Full Text] [Related]
19. Failure of heparin to inhibit the expression of the thrombin receptor following endothelial injury of the rabbit carotid artery.
Guitteny AF; Herbert JM
Eur J Pharmacol; 1997 May; 327(2-3):157-62. PubMed ID: 9200554
[TBL] [Abstract][Full Text] [Related]
20. Development of poly(Lactic acid)/chitosan co-matrix microspheres: controlled release of taxol-heparin for preventing restenosis.
Chandy T; Rao GH; Wilson RF; Das GS
Drug Deliv; 2001; 8(2):77-86. PubMed ID: 11400866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
